Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.52 USD | -3.06% | +4.48% | +3.51% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.51% | 508M | |
+10.53% | 115B | |
+12.26% | 106B | |
-4.33% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.32% | 17.56B | |
-40.50% | 17.32B | |
+6.08% | 14.03B | |
+30.96% | 12.13B |
- Stock Market
- Equities
- TRDA Stock
- News Entrada Therapeutics, Inc.
- Goldman Sachs Adjusts Entrada Therapeutics' Price Target to $10 from $22, Keeps Neutral Rating